TrialJournal for immunotherapy of cancer2024
Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.
Lianjun Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it